Dan Hicklin (File photo)
MPM and Longwood-backed Werewolf Therapeutics grabs $56 million to take tumors by night
Backed with the team from his last company, one of the key developers behind Keytruda has a new warchest in the race to bring immunotherapy …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
